Stock HUM HUMANA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
358.1 USD +3.09% Intraday chart for Humana Inc. +2.53% -21.78%
May. 31 ANALYST RECOMMENDATIONS : Humana, Netapp, Dell, Qualcomm, Paypal... Our Logo
May. 30 Baird Initiates Humana at Neutral Rating With $374 Price Target MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 48,537 54,296 59,622 64,843 56,361 43,154 - -
Enterprise Value (EV) 1 50,149 56,283 68,722 70,908 63,323 48,468 48,089 47,730
P/E ratio 18.2 x 16.2 x 20.5 x 23.2 x 22.9 x 23.7 x 18.2 x 14.5 x
Yield 0.6% 0.61% 0.59% 0.62% - 1.05% 1.13% 1.22%
Capitalization / Revenue 0.75 x 0.7 x 0.72 x 0.7 x 0.53 x 0.38 x 0.37 x 0.35 x
EV / Revenue 0.77 x 0.73 x 0.83 x 0.76 x 0.6 x 0.43 x 0.42 x 0.39 x
EV / EBITDA 13.6 x 13.3 x 21.5 x 13.8 x 11.1 x 12.2 x 10.4 x 8.96 x
EV / FCF 11 x 12 x 72.6 x 20.5 x 21.3 x 25.1 x 15.3 x 13 x
FCF Yield 9.07% 8.31% 1.38% 4.89% 4.7% 3.98% 6.53% 7.67%
Price to Book 4.02 x 3.85 x 3.73 x 4.18 x 3.44 x 2.73 x 2.53 x 2.3 x
Nbr of stocks (in thousands) 132,426 132,341 128,534 126,600 123,111 120,501 - -
Reference price 2 366.5 410.3 463.9 512.2 457.8 358.1 358.1 358.1
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 64,888 77,155 83,064 92,870 106,374 113,997 115,695 121,605
EBITDA 1 3,697 4,240 3,201 5,122 5,711 3,971 4,643 5,328
EBIT 1 3,262 3,751 2,488 4,413 4,999 3,193 3,826 4,542
Operating Margin 5.03% 4.86% 3% 4.75% 4.7% 2.8% 3.31% 3.73%
Earnings before Tax (EBT) 1 3,456 4,600 3,354 3,568 3,383 2,380 3,135 3,771
Net income 1 2,707 3,367 2,933 2,806 2,489 1,800 2,332 2,826
Net margin 4.17% 4.36% 3.53% 3.02% 2.34% 1.58% 2.02% 2.32%
EPS 2 20.10 25.31 22.67 22.08 20.00 15.10 19.73 24.71
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,927 3,139 3,660
FCF margin 7.01% 6.06% 1.14% 3.73% 2.8% 1.69% 2.71% 3.01%
FCF Conversion (EBITDA) 123.02% 110.26% 29.55% 67.69% 52.13% 48.54% 67.62% 68.69%
FCF Conversion (Net income) 168.01% 138.85% 32.25% 123.56% 119.61% 107.06% 134.63% 129.52%
Dividend per Share 2 2.200 2.500 2.725 3.150 - 3.766 4.055 4.361
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 21,054 23,970 23,662 22,799 22,439 26,742 26,747 26,423 26,462 29,611 28,428 27,994 28,015 30,171 29,033
EBITDA 1 434 1,604 1,501 1,200 640 1,875 1,854 1,459 508 1,639 1,259 994.6 256.8 1,458 1,398
EBIT 1 240 1,415 1,313 1,018 458 1,657 1,530 1,258 322 1,397 1,079 799.5 54.65 1,308 1,214
Operating Margin 1.14% 5.9% 5.55% 4.47% 2.04% 6.2% 5.72% 4.76% 1.22% 4.72% 3.8% 2.86% 0.2% 4.33% 4.18%
Earnings before Tax (EBT) 1 -60 1,220 1,122 1,297 -71 1,614 1,262 1,098 -591 1,014 903 709.6 -145.2 1,245 1,123
Net income 1 -14 930 696 1,195 -15 1,239 959 832 -541 741 689.4 477 -135.5 896.3 796.2
Net margin -0.07% 3.88% 2.94% 5.24% -0.07% 4.63% 3.59% 3.15% -2.04% 2.5% 2.43% 1.7% -0.48% 2.97% 2.74%
EPS 2 -0.1100 7.290 5.480 9.390 -0.1200 9.870 7.660 6.710 -4.420 6.110 5.703 3.962 -1.125 7.474 6.653
Dividend per Share 2 0.7000 0.7875 0.7875 0.7875 0.7875 0.8850 0.8850 - - 0.8850 0.9840 0.9800 0.9880 1.007 1.023
Announcement Date 2/2/22 4/27/22 7/27/22 11/2/22 2/1/23 4/26/23 8/2/23 11/1/23 1/25/24 4/24/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,612 1,987 9,100 6,065 6,962 5,314 4,935 4,576
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.436 x 0.4686 x 2.843 x 1.184 x 1.219 x 1.338 x 1.063 x 0.8588 x
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,927 3,139 3,660
ROE (net income / shareholders' equity) 21.7% 19.4% 17.9% 20.4% 20.6% 12.3% 14.6% 17%
ROA (Net income/ Total Assets) 8.84% 12.8% 7.39% 6.42% 7.21% 3.89% 4.7% 5.41%
Assets 1 30,633 26,224 39,664 43,706 34,544 46,284 49,564 52,232
Book Value Per Share 2 91.10 107.0 124.0 123.0 133.0 131.0 142.0 156.0
Cash Flow per Share 2 39.20 42.40 17.50 36.10 32.00 21.70 32.00 41.00
Capex 1 736 964 1,316 1,120 1,004 807 928 997
Capex / Sales 1.13% 1.25% 1.58% 1.21% 0.94% 0.71% 0.8% 0.82%
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Humana Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
358.1 USD
Average target price
369.5 USD
Spread / Average Target
+3.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
HUMANA INC. Stock Humana Inc.
-21.78% 43.15B
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-5.91% 456B
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+14.19% 125B
CIGNA Stock Cigna
+15.08% 97.9B
CENTENE CORPORATION Stock Centene Corporation
-3.53% 38.2B
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-12.93% 18.43B
PROGYNY, INC. Stock Progyny, Inc.
-27.51% 2.57B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-8.59% 1.5B
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Financials Humana Inc.